AUDISTIM Day/Night Alleviates Tinnitus-Related Handicap in Patients with Chronic Tinnitus: A Double-Blind Randomized Placebo-Controlled Trial.

The aim of this study is to evaluate the efficacy of taking a daily supplement based on active compounds (AUDISTIM Day Night: A D/N) in alleviating tinnitus-related disability, as suggested by previous real-life studies. This double-blind randomized placebo-controlled study was conducted in adults with mild to severe tinnitus receiving a 3-month supplementation with A D/N (magnesium, vitamins, phytochemicals) or placebo (excipients without active ingredients). Tinnitus-related handicap (THI), psychological stress (MSP-9), and sleep quality (PSQI) were assessed at baseline and during intervention, perceived impression of tinnitus improvement at the end of the follow-up.

Predictive factors of vertigo following cochlear implantation in adults.

Objectives: The occurrence of vertigo after cochlear implantation surgery is one of the most common complications, and often transient. The purpose of this study was to evaluate the occurrence of vertigo after unilateral or bilateral cochlear implantation as well as to identify potential predictive factors.

Materials And Methods: Patients who have undergone cochlear implantation and vestibular assessment pre- and postoperatively were included retrospectively.

French Society of ENT (SFORL) guidelines (short version): Audiometry in adults and children.

Introduction: French Society of ENT (SFORL) good practice guidelines for audiometric examination in adults and children.

Methods: A multidisciplinary working group performed a review of the scientific literature. Guidelines were drawn up, reviewed by an independent reading group, and finalized in a consensus meeting.

Long term results after cochlear implantation: Schooling and social insertion of teenagers and young adults.

Introduction: To analyse the long-term impact of cochlear implantation (CI) in deaf patients on perception and language, and on schooling and social insertion.

Method: A total of 131 profoundly deaf patients that had unilateral CI, aged at follow up 16 to 26 years old and with 5 years minimum of follow up were included for the study. 84 of them had profound congenital deafness (Gc) and 47 had progressive deafness (Gp).

Benefit of contralateral hearing aid in adult cochlear implant bearers.

Objectives: The present study assessed the interest of a contralateral hearing aid (HA) in adult cochlear implant (CI) bearers.

Material And Methods: The study recruited 10 French-speaking adult HA bearers with postlingual bilateral hearing loss, fitted for at least 2 years with a unilateral CI after loss of benefit from HA in one ear but continuing to use their contralateral HA: 4 male, 6 female; mean age, 58 years. All had regularly used bilateral HAs prior to CI.

Contralateral routing of signal hearing aid versus transcutaneous bone conduction in single-sided deafness.

The aim of this study was to compare a contralateral routing of signal (CROS) hearing aid to a transcutaneous bone-anchored device in the same conditions. This prospective crossover study included 18 adult patients with a single-sided deafness (SSD). After a trial period of 60 days with CROS and 7 days with a transcutaneous bone-anchored device (Alpha 1®, Sophono, Boulder, Colo.

Improvement of cognitive function after cochlear implantation in elderly patients.

Importance: The association between hearing impairment and cognitive decline has been established; however, the effect of cochlear implantation on cognition in profoundly deaf elderly patients is not known.

Objective: To analyze the relationship between cognitive function and hearing restoration with a cochlear implant in elderly patients.

Design, Setting, And Participants: Prospective longitudinal study performed in 10 tertiary referral centers between September 1, 2006, and June 30, 2009.

Predictive factors of cochlear implant outcomes in the elderly.

Objective: To analyze predictive factors of cochlear implant outcomes and postoperative complications in the elderly.

Study Design: Prospective, longitudinal study performed in 10 tertiary referral centers.

Methods: Ninety-four patients aged 65-85 years with a profound, postlingual hearing loss were evaluated before implantation, at time of activation, and 6 and 12 months after cochlear implantation.

European multi-centre study of the Nucleus Hybrid L24 cochlear implant.

Objectives: To investigate the preservation of residual hearing in subjects who received the Nucleus Hybrid L24 cochlear implant. To investigate the performance benefits up to one year post-implantation in terms of speech recognition, sound quality, and quality of life.

Design: Prospective, with sequential enrolment and within-subject comparisons.

Results of a multicenter clinical study evaluating a new Smart algorithm to measure neural response imaging.

Objective: To evaluate the smart algorithm in speed and reliability of threshold estimation compared with the algorithm available in the standard fitting software and to evaluate the possibility of using programs based on the smart algorithm instead of programs derived from behavioral measures.

Patients: Twenty subjects unilaterally implanted with a CII Bionic Ear or HiRes90K device.

Interventions: Neural response imaging thresholds (tNRI) were measured using both the smart approach within the Research Studies Platform for Objective Measures and the SoundWave fitting software.

Clinical evaluation of cochlear implant sound coding taking into account conjectural masking functions, MP3000™.

Efficacy of the SPEAK and ACE coding strategies was compared with that of a new strategy, MP3000™, by 37 European implant centers including 221 subjects. The SPEAK and ACE strategies are based on selection of 8-10 spectral components with the highest levels, while MP3000 is based on the selection of only 4-6 components, with the highest levels relative to an estimate of the spread of masking. The pulse rate per component was fixed.

[Vascular involvement in Cogan's syndrome. A case report].

Vascular manifestations of Cogan's syndrome are rarely reported. We report the case of a young woman followed for typical Cogan's disease. Serious vascular involvement was found only during work-up for arterial hypertension.

Comparison of three types of French speech-in-noise tests: a multi-center study.

Objective: To compare results on the everyday sentence test 'FIST', the new closed-set sentence test 'FrMatrix', and the digit triplet screening test 'FrDigit3'.

Design: First, the FrMatrix was developed and normative values were obtained. Subsequently, speech reception thresholds (SRTs) for the three types of tests were gathered at four study centers representing different geographic regions in Belgium and France.

Benefits of the HiRes 120 coding strategy combined with the Harmony processor in an adult European multicentre study.

Conclusion: The Harmony processor was found to be reliable, comfortable and offered a substantially increased battery life compared with the previous generation processor. No significant improvement in speech understanding with HiRes was demonstrated from objective measures, but the majority of subjects showed a clear subjective preference for the combination HiRes 120/Harmony processor.

Objectives: To evaluate experience with the Harmony™ sound processor, together with the HiRes 120 strategy.

The French digit triplet test: a hearing screening tool for speech intelligibility in noise.

A French speech intelligibility screening test in noise that applies digit triplets as stimuli has been developed and evaluated for both telephone and broadband headphone use. After optimizing the speech material based on the intelligibility of the individual digits, norms for normal-hearing subjects were established. speech reception thresholds (SRTs) of -6.

[Management of hearing impairment in adults].

Hearing impairment, mainly the deafness with possible distortions, assorted with tinnitus concerns about 4 million of the French population. It can be of variable severity. Deafness is an invisible disability until we must answer a question.

[Study of a case of cochlear implant with recurrent cutaneous extrusion].

Objective: An observation of a difficult-to-diagnose complication of the cochlear implant: recurring cutaneous extrusion of a cochlear implant is reported.

Patients And Methods: The history of an adult patient with total deafness is reported. She received an implant in her right ear in 1988, which was then explanted because of absence of hearing results.

[Hearing loss in adults].

The management of hearing loss in adults depends of etiology and its severity. It can be as simple as treating an external otitis, removing an impacted cerumen or a more complex one such as a surgery for otosclerosis. The hearing loss is managed mainly by new advances in hearing aids technology and implantable hearing devices which include BAHA, middle ear implant and cochlear implants.

[Adult deafness: hearing aid or hearing repair...].

With the increase in lifespan, presbyacusis is a common situation. It starts with the difficulty of understanding in noisy conditions and may extend to withdrawal of social activity because we do not face the unintelligibility during diners and meetings. But, with difficulty, the hearing impaired confesses his deafness and hardly recognizes "his" presbyacusis.

Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2.

Conclusions: New technological developments will most probably improve the efficiency of auditory brainstem implantation (ABI). Meanwhile, cochlear implantation in patients who have undergone prior reductive surgery, and who have maintained a positive electric stimulation, is an excellent alternative for rehabilitating complete and bilateral hearing loss in patients with neurofibromatosis type 2 (NF2). Auditory results are far better than those reported after ABI.

Benefit of the Vibrant Soundbridge device in patients implanted for 5 to 8 years.

Objectives: To assess audiological performance, satisfaction rate, and side effects of 100 patients who have been using the middle ear implant Vibrant Soundbridge (VSB) for 5 to 8 yr when compared with data collected from 3 to 18 mo postsurgery.

Design: Audiological testing and subjective evaluation using self-assessment scales were performed in 77 out of the 100 patients using the VSB for 5 to 8 years. The results were compared to data collected 3 months (audiological testing) and 18 months (self-assessment scales) after surgery.